1. Home
  2. DNLI vs SKYW Comparison

DNLI vs SKYW Comparison

Compare DNLI & SKYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • SKYW
  • Stock Information
  • Founded
  • DNLI 2013
  • SKYW 1972
  • Country
  • DNLI United States
  • SKYW United States
  • Employees
  • DNLI N/A
  • SKYW N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • SKYW Air Freight/Delivery Services
  • Sector
  • DNLI Health Care
  • SKYW Consumer Discretionary
  • Exchange
  • DNLI Nasdaq
  • SKYW Nasdaq
  • Market Cap
  • DNLI 3.3B
  • SKYW 4.2B
  • IPO Year
  • DNLI 2017
  • SKYW N/A
  • Fundamental
  • Price
  • DNLI $20.84
  • SKYW $101.08
  • Analyst Decision
  • DNLI Strong Buy
  • SKYW Buy
  • Analyst Count
  • DNLI 11
  • SKYW 4
  • Target Price
  • DNLI $40.40
  • SKYW $107.25
  • AVG Volume (30 Days)
  • DNLI 867.7K
  • SKYW 348.9K
  • Earning Date
  • DNLI 02-25-2025
  • SKYW 01-30-2025
  • Dividend Yield
  • DNLI N/A
  • SKYW N/A
  • EPS Growth
  • DNLI N/A
  • SKYW N/A
  • EPS
  • DNLI N/A
  • SKYW 5.85
  • Revenue
  • DNLI N/A
  • SKYW $3,335,305,000.00
  • Revenue This Year
  • DNLI N/A
  • SKYW $21.31
  • Revenue Next Year
  • DNLI $420.35
  • SKYW $8.57
  • P/E Ratio
  • DNLI N/A
  • SKYW $17.27
  • Revenue Growth
  • DNLI 204.74
  • SKYW 16.42
  • 52 Week Low
  • DNLI $14.56
  • SKYW $48.28
  • 52 Week High
  • DNLI $33.33
  • SKYW $117.51
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 35.14
  • SKYW 41.02
  • Support Level
  • DNLI $19.93
  • SKYW $98.87
  • Resistance Level
  • DNLI $21.64
  • SKYW $102.22
  • Average True Range (ATR)
  • DNLI 0.96
  • SKYW 2.91
  • MACD
  • DNLI -0.06
  • SKYW -0.62
  • Stochastic Oscillator
  • DNLI 21.56
  • SKYW 22.91

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About SKYW SkyWest Inc.

SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. Generally, SkyWest provides regional flights, and utilizes its smaller, lower-cost aircraft to carry passengers that booked tickets through airlines. It partners with carriers across the world to fly and operate aircraft for a fee. SkyWest may use the carriers brand and ground support to coordinate marketing and easily transport passengers. The company has two reportable segments: SkyWest Airlines and SkyWest Leasing.

Share on Social Networks: